| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968521 | Vaccine | 2013 | 5 Pages |
Abstract
⺠12.2% of women in a Canadian cervical cancer screening program are hrHPV positive. ⺠Highest rate in 20-24-year old women. ⺠HPV 16 was most prevalent sub-type. ⺠Agreement using three commercial genotyping methods for HPV 16 and 18 was high.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
G.S. Ogilvie, D.A. Cook, D.L. Taylor, C. Rank, L. Kan, A. Yu, W. Mei, D.J. van Niekerk, A.J. Coldman, M. Krajden,